3 results
Search Results
2. Cover: Journal of the Chinese Chemical Society 8/2022.
- Subjects
CHEMISTS ,CATALYSIS ,BIOCHEMISTRY ,EXPERTISE ,ANNIVERSARIES - Abstract
The Chemical Society located in Taipei is celebrating the 90th anniversary of its inception. We launch a special issue dedicated to this important occasion. In this special issue, we invite chemists from Taiwan across a broad range of disciplines and expertise to showcase the diversity and activity of chemical research carried out in Taiwan There are 13 review papers and 21 research articles, covering a variety of topics such as catalysis, biochemistry, synthesis, and materials chemistry. Please join us to find out more interesting research in this issue. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
3. Comparison of Clinical Outcomes of Radical Prostatectomy versus IMRT with Long-Term Hormone Therapy for Relatively Young Patients with High- to Very High-Risk Localized Prostate Cancer.
- Author
-
Shih, Hung-Jen, Chang, Shyh-Chyi, Hsu, Chia-Hao, Lin, Yi-Chu, Hung, Chu-Hsuan, and Wu, Szu-Yuan
- Subjects
PROSTATE tumors treatment ,THERAPEUTICS ,BIOCHEMISTRY ,REPORTING of diseases ,HORMONES ,CONFIDENCE intervals ,RADICAL prostatectomy ,MULTIVARIATE analysis ,TREATMENT duration ,CANCER relapse ,METASTASIS ,TREATMENT effectiveness ,COMPARATIVE studies ,RADIATION doses ,DESCRIPTIVE statistics ,RADIOTHERAPY ,DEATH ,PROBABILITY theory ,PROPORTIONAL hazards models ,CANCER patient medical care ,LONGITUDINAL method ,EVALUATION - Abstract
Simple Summary: That the definitive optimal treatments for relatively young men (aged ≤ 65 years) with high- or very high-risk localized prostate cancer (HR/VHR-LPC) are radical prostatectomy (RP) or radiation plus antiandrogen therapy (RT-ADT) is controversial. To the best of our knowledge, our study is the first and largest to examine biochemical failure (BF), all-cause death, locoregional recurrence, and distant metastasis in relatively young men with HR/VHR-LPC as defined by National Comprehensive Cancer Network risk strata. After head-to-head propensity score matching was used to balance the potential confounders, a multivariable Cox proportional hazards regression model was used to analyze oncologic outcomes. In relatively young men with HR/VHR-LPC, RP and RT-ADT yielded similar oncologic outcomes and RP reduced the risk of BF compared with RT-ADT. That intensity-modulated radiotherapy (IMRT) plus antiandrogen therapy (IMRT-ADT) and radical prostatectomy (RP) are the definitive optimal treatments for relatively young patients (aged ≤ 65 years) with high- or very high-risk localized prostate cancer (HR/VHR-LPC), but remains controversial. We conducted a national population-based cohort study by using propensity score matching (PSM) to evaluate the clinical outcomes of RP and IMRT-ADT in relatively young patients with HR/VHR-LPC. Methods: We used the Taiwan Cancer Registry database to evaluate clinical outcomes in relatively young (aged ≤ 65 years) patients with HR/VHR-LPC, as defined by the National Comprehensive Cancer Network risk strata. The patients had received RP or IMRT-ADT (high-dose, ≥72 Gy plus long-term, 1.5–3 years, ADT). Head-to-head PSM was used to balance potential confounders. A Cox proportional hazards regression model was used to analyze oncologic outcomes. Results: High-dose IMRT-ADT had a higher risk of biochemical failure (adjusted hazard ratio [aHR] = 2.03, 95% confidence interval [CI] 1.56–2.65, p < 0.0001) compared with RP; IMRT-ADT did not have an increased risk of all-cause death (aHR = 1.2, 95% CI 0.65–2.24, p = 0.564), locoregional recurrence (aHR = 0.88, 95% CI 0.67–1.06, p = 0.3524), or distant metastasis (aHR = 1.03, 95% CI 0.56–1.9, p = 0.9176) compared with RP. Conclusion: In relatively young patients with HR/VHR-LPC, RP and IMRT-ADT yielded similar oncologic outcomes and RP reduced the risk of biochemical failure compared with IMRT-ADT. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.